Chromosome Aberrations
Showing 51 - 75 of 711
Dry Eye in Turner Syndrome and Premature Ovarian Failure
Completed
- Turner Syndrome
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 13, 2018
Secondary Myelodysplastic Syndrome, Therapy-Related Myelodysplastic Syndrome Trial in Columbus (Azacitidine, Quality-of-Life
Recruiting
- Secondary Myelodysplastic Syndrome
- Therapy-Related Myelodysplastic Syndrome
- Azacitidine
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 1, 2022
Clubfoot Trial in Zürich (Gait analysis)
Active, not recruiting
- Clubfoot
- Gait analysis
-
Zürich, SwitzerlandDr.Joller BioMedical Consulting
Jun 21, 2023
Mild-to-Moderate Obstructive Sleep Apnea: Inflammation vs.
Enrolling by invitation
- Obstructive Sleep Apnea
-
Hershey, PennsylvaniaPenn State College of Medicine, Penn State Milton S. Hershey Med
Jan 26, 2023
A Taiwanese Oncogenetic Panel and Integrated Clinical Data
Recruiting
- Thyroid Cancer
- A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients
-
Kaohsiung, Taiwan
- +7 more
Sep 12, 2022
Down Syndrome Trial in Paris (Biological sampling)
Recruiting
- Down Syndrome
- Biological sampling
-
Paris, FranceInstitut Jérôme Lejeune
Mar 1, 2023
Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
Recruiting
- Chronic Phase Chronic Myelogenous Leukemia
- +3 more
- Dasatinib
- Decitabine and Cedazuridine
-
Houston, TexasM D Anderson Cancer Center
Aug 11, 2022
Oncogenetic Panel and Integrated Clinical Data Registry Study
Recruiting
- Gastrointestinal Stromal Tumor (GIST)
-
Changhua, Taiwan
- +12 more
Dec 6, 2022
Myopia Trial in Damietta (Implantable Collamer Lens (ICL), Implantable Intraocular Lens (IPCL))
Completed
- Myopia
- Implantable Collamer Lens (ICL)
- Implantable Intraocular Lens (IPCL)
-
Damietta, EgyptAkram Fekry Elgazzar
Sep 22, 2023
BMI, Physical Fitness and Motor Skills in Down's Syndrome
Recruiting
- Down Syndrome
-
Lahore, Punjab, PakistanRiphah International University
Jun 6, 2023
Urothelial Carcinoma Trial in Worldwide (Derazantinib dose level 1 (300mg once daily) monotherapy, Derazantinib various dose
Completed
- Urothelial Carcinoma
- Derazantinib dose level 1 (300mg once daily) monotherapy
- +4 more
-
Newnan, Georgia
- +65 more
Oct 19, 2022
Philadelphia-Positive ALL Trial in Suzhou (Olverembatinib)
Not yet recruiting
- Philadelphia-Positive ALL
-
Suzhou, Jiangsu, ChinaFirst Affiliated Hospital of Soochow University
Jul 1, 2023
Mini-Monovision BetweenMonofocal andAdjustable Intraocular Lens
Not yet recruiting
- Cataract
- Clareon Monofocal
- Light-Adjustable Lens
-
Gainesville, GeorgiaGainesville Eye Associates
Nov 3, 2023
Acute Lymphoblastic Leukemia Trial in Suzhou (cladribine, cytarabine,venetoclax)
Recruiting
- Acute Lymphoblastic Leukemia
- cladribine, cytarabine,venetoclax
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Dec 22, 2022
Muscular Atrophy, Spinal Trial
Not yet recruiting
- Muscular Atrophy, Spinal
- (no location specified)
Nov 8, 2022
Asian Multicenter Prospective Study of ctDNA Sequencing
Recruiting
- Cervical Cancer
- +5 more
- NGS analysis of ctDNA
-
Tokyo, Japan
- +18 more
Sep 28, 2022
Keratoconus Trial (Customized contact lens)
Not yet recruiting
- Keratoconus
- Customized contact lens
- (no location specified)
Nov 23, 2021
Associated With Colorectal Cancer
Not yet recruiting
- Colorectal Neoplasms
- Assessment of smoking ,heavy metal, organophosphorus exposure and d) Mutational analysis of the KRAS and BRAF genes:
- (no location specified)
Dec 18, 2021
Acute Lymphoblastic Leukemia (ALL) Trial (Nilotinib)
No longer available
- Acute Lymphoblastic Leukemia (ALL)
- (no location specified)
Aug 5, 2022
Dysphotopsia Trial (diagnostic of optical aberrations)
Not yet recruiting
- Dysphotopsia
- diagnostic of optical aberrations
- (no location specified)
Aug 23, 2022
Advanced or Metastatic Solid Tumor, Advanced or Metastatic Gastric or Gastroesophageal Cancer, Myeloid or Lymphoid Tumors (MLN)
Active, not recruiting
- Advanced or Metastatic Solid Tumor
- +2 more
-
Gilbert, Arizona
- +60 more
Oct 20, 2022
Relapsed/Refractory Philadelphia Positive B-precursor ALL Trial in Worldwide (Blinatumomab)
Completed
- Relapsed/Refractory Philadelphia Positive B-precursor ALL
-
Duarte, California
- +21 more
Sep 8, 2022